Login to Your Account



Bulge Bracket Breakdown

Short-Term Biotech Impact Mild, Long-Term Remains to be Seen

By Trista Morrison


Monday, September 29, 2008
The biotech industry tends to be somewhat resistant to macroeconomic forces, given the constant demand for healthcare. But the industry isn't totally insulated from the recent events on Wall Street, including Lehman's bankruptcy, Merrill Lynch's acquisition by Bank of America and the news that Goldman Sachs and Morgan Stanley are moving into commercial banking. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription